The PompeQoL questionnaire: Development and validation of a new measure for children and adolescents with Pompe disease
Journal of Inherited Metabolic Disease · 2024
DOI: 10.1002/jimd.12777 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Journal of Inherited Metabolic Disease, 2024. Verfasst von Moritz Ilan Truninger und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Metabolism, Children's Research Centre, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Glycogen Storage Disease Type II, Quality of Life. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sanofi.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Genetic disorders pose great challenges for affected individuals and their families, as they must cope with the irreversible nature of the disease and a life‐long dependence on medical assistance and treatment. Children and adolescents dealing with Pompe disease (PD) often struggle to keep up with their peers in physical activities. To gain valuable insights into their subjective experiences and better understand their perception and coping related to daily challenges linked to their condition and treatment, the use of standardized questionnaires is crucial. This study introduces the novel PompeQoL 1.0 questionnaire for children and adolescents with PD, designed for comprehensive assessment of both disease‐specific FDH and HRQoL through self‐ and proxy reports. Content validity was ensured through patients' and parents' involvement at the initial stages of development and in subsequent cognitive debriefing process. Participants found the questionnaire easy to understand, answerable, relevant, and comprehensive. Adjustments based on feedback from patients and their parents improved its utility as a patient‐ and observer‐reported outcome measure. After careful item examination, 52 items were selected, demonstrating moderate to excellent test–retest reliability for most scales and initial evidence for satisfactory construct validity. The PompeQoL questionnaire stands as a valuable screening instrument for both clinical and research purposes. Future research should prioritize additional revisions and larger validation studies, focusing on testing the questionnaire in clinical practice and trials. Nevertheless, the PompeQoL 1.0 stands out as the first standardized measure providing insights into disease‐specific FDH and HRQoL among children and adolescents with various forms of PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Metabolism, Children's Research Centre, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland.
- Department of Psychosomatics and Psychiatry, University Children's Hospital Zurich, Zurich, Switzerland.
- Division of Child and Adolescent Health Psychology, Institute of Psychology, University of Zurich, Zürich, Switzerland.
- Department of Child Neurology, Justus-Liebig-University Gießen, Gießen, Germany.
- Villa Metabolica, Center for Pediatric and Adolescent Medicine, University Medical Center Mainz, Mainz, Germany.
- Institute for Inherited Metabolic Diseases and Department of Pediatrics, Paracelsus Medical University Salzburg, Salzburg, Austria.
ORCID-Profile: Moritz Ilan Truninger, Helene Werner, Markus Andreas Landolt, Martina Huemer
Förderung
- Sanofi
Zitieren
APA
Truninger, M. I., Werner, H., Landolt, M. A., Hahn, A., Hennermann, J. B., Lagler, F. B., Möslinger, D., Pfrimmer, C., Rohrbach, M., & Huemer, M. (2024). The PompeQoL questionnaire: Development and validation of a new measure for children and adolescents with Pompe disease. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.12777
Vancouver
Truninger MI, Werner H, Landolt MA, Hahn A, Hennermann JB, Lagler FB, et al. The PompeQoL questionnaire: Development and validation of a new measure for children and adolescents with Pompe disease. Journal of Inherited Metabolic Disease. 2024. doi:10.1002/jimd.12777
BibTeX
@article{Truninger2024,
author = {Truninger, Moritz Ilan and Werner, Helene and Landolt, Markus Andreas and Hahn, Andreas and Hennermann, Julia B and Lagler, Florian B and Möslinger, Dorothea and Pfrimmer, Charlotte and Rohrbach, Marianne and Huemer, Martina},
title = {The PompeQoL questionnaire: Development and validation of a new measure for children and adolescents with Pompe disease},
journal = {Journal of Inherited Metabolic Disease},
year = {2024},
doi = {10.1002/jimd.12777}
}
EUVIMED